CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Investors›
Catalio Capital Management
Catalio Capital Management logo

Catalio Capital Management

Operating Status: Operating

Catalio Capital Management: A venture capital firm investing in breakthrough biomedical technology.

Location
New York City, NY, US
Founded
2020
Firm
Compare
Portfolio
Fundraising
Employees
News
Library

Catalio Capital Management was created by George Petrocheilos and Dr.

Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Management, an elite group of world-renowned, serial scientist-entrepreneurs.

Catalio Capital Management - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Portfolio Companies44
Follow-on Investments11
Current Portfolio Count43
Total Portfolio Exits1

Top Investment Stages

Series B18 (36.0%)
Series A16 (32.0%)
Series C7 (14.0%)
Series D7 (14.0%)
Seed2 (4.0%)

Stage Mix

Series B 36%Series A 32%Series C 14%Series D 14%Seed 4%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Enveda Biosciences logo

Enveda Biosciences

Evvy logo

Evvy

Imbria Pharmaceuticals logo

Imbria Pharmaceuticals

Alentis Therapeutics logo

Alentis Therapeutics

OnCusp Therapeutics logo

OnCusp Therapeutics

Lassen Therapeutics logo

Lassen Therapeutics

Odyssey Therapeutics logo

Odyssey Therapeutics

RefleXion Medical logo

RefleXion Medical

Sanguine logo

Sanguine

Iambic Therapeutics logo

Iambic Therapeutics

Avalyn Pharma logo

Avalyn Pharma

Rejuveron Life Sciences logo

Rejuveron Life Sciences

Noetik logo

Noetik

Star Therapeutics logo

Star Therapeutics

Georgiamune logo

Georgiamune

Septerna logo

Septerna

Volastra Therapeutics logo

Volastra Therapeutics

Setpoint Medical logo

Setpoint Medical

NextPoint Therapeutics logo

NextPoint Therapeutics

Spiral Therapeutics logo

Spiral Therapeutics

Metagenomi logo

Metagenomi

Perceive Biotherapeutics logo

Perceive Biotherapeutics

Ensoma logo

Ensoma

Medical Informatics logo

Medical Informatics

Cartography Biosciences logo

Cartography Biosciences

Catalio Capital Management - Classification

Also Known As
  • Catalio Capital Management LP
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 5 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end

Catalio Capital Management - Similar Investment Firms

Bold Capital Partners logo

Bold Capital Partners

Thiel Capital logo

Thiel Capital

thielcapital.com

Cato BioVentures logo

Cato BioVentures

Cote Capital logo

Cote Capital

cotecapital.com

BioImpact Capital logo

BioImpact Capital

Altium Capital logo

Altium Capital

altiumcap.com

Pathfinder Venture Capital Funds logo

Pathfinder Venture Capital Funds

Codon Capital logo

Codon Capital

codoncapital.com

Capital V logo

Capital V

capitalv.vc

Catalyst Health Ventures logo

Catalyst Health Ventures

Health Catalyst Capital logo

Health Catalyst Capital

Transhuman Capital logo

Transhuman Capital

Coelius Capital logo

Coelius Capital

coelius.vc

Catalyst Capital Management logo

Catalyst Capital Management

Catalysta Ventures logo

Catalysta Ventures